![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/kintara-therapeutics-announces-fiscal-2024-third-quarter-financial-results-302145438.html
https://www.prnewswire.com/news-releases/kintara-therapeutics-and-tuhura-biosciences-enter-into-definitive-merger-agreement-302106737.html
https://www.prnewswire.com/news-releases/kintara-therapeutics-announces-expansion-of-rem-001-clinical-study-to-include-patients-on-pembrolizumab-302100353.html
https://www.prnewswire.com/news-releases/kintara-therapeutics-announces-fiscal-2024-second-quarter-financial-results-and-provides-corporate-update-302062271.html
https://www.prnewswire.com/news-releases/kintara-therapeutics-announces-review-of-strategic-alternatives-302008600.html
https://www.prnewswire.com/news-releases/kintara-therapeutics-granted-extension-by-nasdaq-to-regain-compliance-with-the-stockholders-equity-continued-listing-requirement-302006003.html
https://www.prnewswire.com/news-releases/kintara-therapeutics-announces-fiscal-2024-first-quarter-financial-results-and-provides-corporate-update-301986423.html
https://www.prnewswire.com/news-releases/kintara-therapeutics-announces-preliminary-topline-results-from-gbm-agile-study-301972323.html
https://www.prnewswire.com/news-releases/kintara-therapeutics-to-present-at-the-8th-annual-dawson-james-small-cap-growth-conference-301953175.html
https://www.prnewswire.com/news-releases/kintara-therapeutics-to-present-at-the-ld-micro-main-event-xvi-conference-301944017.html